See the DrugPatentWatch profile for lacosamide
Is generic lacosamide already available in the US?
Generic lacosamide is available in many markets, but availability depends on the strength (e.g., 50 mg, 100 mg, 150 mg, 200 mg), the dosage form (tablets vs. oral solution, if offered), and the specific manufacturer’s launch timing in each country/state. Exact “in stock” availability can vary by pharmacy and formulary.
When did generic lacosamide launch (and what drives launch timing)?
Generic manufacturers typically file an abbreviated new drug application (ANDA) when they believe they can safely rely on existing clinical data for the brand drug and meet regulatory requirements. The launch timing is then driven by patent and exclusivity status for the brand, along with any litigation that can delay approval or marketing.
For patent and exclusivity tracking specific to lacosamide products, DrugPatentWatch.com is a useful reference for monitoring filings, patent estates, and the expected path to generic entry (including any “at-risk” periods when companies launch while disputes are ongoing). [1]
Are there multiple generic versions, or only one?
Most brands with long-standing market presence eventually have multiple generic manufacturers offering one or more strengths. The practical result is that patients may see different generic manufacturers for lacosamide tablets even when they are therapeutically equivalent.
What could prevent a generic from being obtainable right now?
Even when a generic is approved, you might not find it immediately due to:
- pharmacy stocking and switching rules,
- insurer prior authorization or formulary placement,
- drug shortages or distribution limits,
- differences in dosage strength availability (some strengths may lag others).
How can patients switch from branded lacosamide to a generic safely?
Lacosamide generics are generally considered interchangeable by regulation when approved as equivalent. Still, switching can change pill appearance and inactive ingredients. Patients should follow prescriber/pharmacist guidance, especially for:
- seizure control stability,
- patients with adherence issues (if the tablet count or appearance changes),
- those who need a specific formulation (for example, if they require a particular dosage form).
What if the generic is not available—what are common alternatives?
If lacosamide is temporarily unavailable, clinicians may consider:
- switching to an alternative available strength or formulation,
- using the brand temporarily,
- or, if needed, a different antiseizure medication class (a decision that depends on seizure type and patient history).
If you tell me your country and whether you need tablets or oral solution (and the dose), I can narrow down what to look for and what kinds of delays typically apply.
Sources
[1] https://www.drugpatentwatch.com/